OncoImmunology, 2162-4011

Journal

More filtering options
  1. 2019
  2. Immunological monitoring of newly diagnosed CML patients treated with bosutinib or imatinib first-line

    Kreutzman, A., Yadav, B., Brummendorf, T. H., Gjertsen, B. T., Lee Hee, M., Janssen, J., Kasanen, T., Koskenvesa, P., Lofti, K., Markevärn, B., Olsson-Strömberg, U., Stentoft, J., Stenke, L., Söderlund, S., Udby, L., Johan Richter, Hjorth-Hansen, H. & Mustjoki, S., 2019 Jul 13, In : OncoImmunology. 8, 9, e1638210.

    Research output: Contribution to journalArticle

  3. Immunoprofiles of colorectal cancer from Lynch syndrome

    Walkowska, J., Kallemose, T., Göran Jönsson, Mats Jönsson, Andersen, O., Andersen, M. H., Svane, I. M., Langkilde, A., Mef Nilbert & Therkildsen, C., 2019, In : OncoImmunology. 8, 1, e1515612.

    Research output: Contribution to journalArticle

  4. 2018
  5. Dynamic evaluation of the immune infiltrate and immune function genes as predictive markers for neoadjuvant chemotherapy in hormone receptor positive, HER2 negative breast cancer

    Matikas, A., Lövrot, J., Ramberg, A., Eriksson, M., Lindsten, T., Lekberg, T., Ingrid Hedenfalk, Niklas Loman, Bergh, J., Hatschek, T., Erlandsson, A. & Foukakis, T., 2018, In : OncoImmunology. 7, 9, e1466017.

    Research output: Contribution to journalArticle

  6. Long-peptide vaccination with driver gene mutations in p53 and Kras induces cancer mutation-specific effector as well as regulatory T cell responses

    Quandt, J., Schlude, C., Michael Bartoschek, Will, R., Cid-Arregui, A., Schölch, S., Reissfelder, C., Weitz, J., Schneider, M., Wiemann, S., Momburg, F. & Beckhove, P., 2018, In : OncoImmunology. 7, 12, e1500671.

    Research output: Contribution to journalArticle

  7. Macrophage-derived lipocalin-2 transports iron in the tumor microenvironment

    Mertens, C., Mora, J., Ören, B., Grein, S., Winslow, S., Scholich, K., Weigert, A., Per Malmström, Carina Forsare, Mårten Fernö, Schmid, T., Brüne, B. & Jung, M., 2018, In : OncoImmunology. 7, 3, e1408751.

    Research output: Contribution to journalArticle

  8. 2015
  9. Kick-starting the cancer-immunity cycle by targeting CD40

    Ellmark, P., Mangsbo, S. M., Furebring, C., Totterman, T. H. & Norlen, P., 2015, In : OncoImmunology. 4, 7, p. e1011484

    Research output: Contribution to journalDebate/Note/Editorial

  10. Role of natural killer cell subsets and natural cytotoxicity receptors for the outcome of immunotherapy in acute myeloid leukemia.

    Martner, A., Rydström, A., Riise, R. E., Aurelius, J., Anderson, H., Brune, M., Foà, R., Hellstrand, K. & Thorén, F. B., 2015, In : OncoImmunology. 5, 1, p. e1041701

    Research output: Contribution to journalArticle

  11. 2014
  12. Local CTLA4 blockade effectively restrains experimental pancreatic adenocarcinoma growth in vivo.

    Sandin, L. C., Eriksson, F., Ellmark, P., Loskog, A. S., Tötterman, T. H. & Mangsbo, S. M., 2014, In : OncoImmunology. 3, 1, p. e27614

    Research output: Contribution to journalArticle

  13. Toll-like receptor genetic variants and colorectal cancer.

    Weber, A. N. & Asta Försti, 2014, In : OncoImmunology. 3, 1, p. e27763

    Research output: Contribution to journalDebate/Note/Editorial

  14. 2012
  15. S100A9 and tumor growth.

    Tomas Leanderson & Fredrik Ivars, 2012, In : OncoImmunology. 1, 8, p. 1404-1405

    Research output: Contribution to journalArticle